Own your ow legal marijuana business | Your guide to making money in the multi-billion dollar marijuana industry |
Major Studies of Drugs and Drug Policy | ||||
Canadian Senate Special Committee on Illegal Drugs | ||||
Volume 2 - Policies and Practices In Canada |
|
Chapter 12
The National Legislative Context
Drugs have been prohibited for fewer than one hundred years;
cannabis for slightly more than 75. It is tempting to think that the decisions
made over the years to use criminal law to fight the production and use of
certain drugs are in keeping with social progress and the advancement of
scientific knowledge about drugs. But
is this really the case? Is civilization one long march towards progress,
towards greater, and increasingly invincible, rationality? If we consider the
state of the planet and the alarms sounded by more than one scientist today, we
may have our doubts. From a social standpoint, the twentieth century has not
brought fewer wars, less destruction, or more equality between people than
previous centuries. With respect to drugs, is the legislation a more or less
faithful translation of scientific knowledge for the greater good of all? Can
we discern a rational structure in the national laws and international
conventions that govern certain drugs and other substances? Are they based on
knowledge of the effects of drugs on the psyche and human behaviour? Do they
reflect the desire to ensure the well-being of the public? The history of legislation governing illegal drugs
in Canada, like the analysis in Chapter 19 of the structure of
international conventions, suggests that this is highly doubtful. We do not
deny that knowledge has advanced; the second part of our report testifies to
this. But scientific knowledge itself is a structure that develops in a given
historical context and responds to paradigms in the way problems are posed and
research is conducted. The dominant scientific positivism is a temporary result
in the long evolution of knowledge. It is not the “end of the story”.
Within the scientific process, a “selection” is made of pertinent questions and ways in which to
ask them, such that any question is not necessarily a good question and certain
ways of answering are more acceptable to the community of researchers. Moreover,
legislation adopted by parliaments is influenced at least as much by prejudices
and preconceptions resulting from “pop science” as by
partisan, personal and international considerations. In this sense, the
parliamentarian is no different from any other citizen, as we pointed out in
the report’s general introduction. We
were told several times that we could not compare the effects of cannabis to
those of alcohol or tobacco. And yet, even at the risk of being unreadable if
not unacceptable to the community, public policy on “drugs” must
propose some rationale of the type: “this is prohibited, because…, and this is not,
because…”.
Most of the time the “reason” – or
the justification? – is presented as risks or dangers on the one hand and as
medical usefulness on the other. Thus, under the current control regime,
because of the risks or dangers they are believed to present, some drugs must
be regulated, that is, they are not sold over the counter. When they present a
danger and they have no known
medical application, the regulatory controls prohibit their manufacture,
production, growth, use, possession, etc., entirely. That is the case with the
legislation and conventions governing opium and its derivatives (heroin), the
coca plant and its derivatives (cocaine, crack) and the cannabis plant and its
derivatives (marijuana, hashish). When the drug presents a danger but is
medically useful, it is subject to more or less severe regulatory controls.
That is the case with benzodiazepines and other powerful medications, which are
sold by pharmacists and cannot be obtained without a medical prescription.
Other drugs present a “health
risk”:
nicotine, alcohol, as well as several other over-the-counter drugs. The
packaging must indicate the risks (except for alcohol – which is very telling)
so as to “warn” the
user. To
what extent is such reasoning really rational? Three researchers at the University of Toronto
(Lazarou, Pomeranz, Corey, 1998) have estimated that correctly prescribed legal
medications kill, on average, 100,000 people a year in North America. Although
for methodological reasons that figure was cut back by one half or two thirds,
it nonetheless illustrates the enormous losses of human life that go undetected
by any monitoring system, including the legal system. No one thinks that this
danger should be avoided by prohibiting medical prescriptions - the risky
decisions made by physicians - or denying the "right to use"
medications. Why? Because we do not see how that solution could be preferable
to the solution of taking risks responsibly. Knowing that this problem exists,
we will try to find other solutions, such as better quality control for the products,
etc. Nor (fortunately) do we consider assigning criminal responsibility to
physicians for taking the risk of writing a correct prescription, knowing that
even correctly prescribed medications can cause death. [1][1] The
2001 report from the International Narcotics Control Board indicates a “worrisome”
increase in the abuse of various prescription drugs in the United States and
notes that several of these medications are found on the black market, in
particular through the Internet.[2][2] Tobacco use causes more than 400,000 deaths a year
in the United States, and approximately 45,000 in Canada. As for alcohol, it is
linked to physical aggression and violence, especially marital, and to road
accidents, and its abuse causes thousands of deaths each year. It
is a mistake to see illegal drugs in a separate category from the legal drugs
insofar as the history of criminalization is concerned. We have compounded that
difficulty today because we do not tend to see the legal drugs in the same
limelight as the illegal drugs. To demonstrate that, we use the phrase
"alcohol and drugs" as if alcohol were not a drug, as if police
officers who go to domestic disputes do not know already that the major drug
problem they will likely find at that dispute is alcohol abuse, as if we do not
already know that more than 70 per cent of all homicides involve alcohol abuse
as a critical factor. For us to pretend that the consumption of alcohol is on a
morally different plane from the consumption of illegal drugs seems to be a
kind of cultural folly that speaks volumes about the cultural blinders we wear
as we go about our business in everyday life. [3][3] Is
the rationale of the system of controls acceptable in the eyes of civil
society, users as well as abstainers? What criteria motivated the legislators’
decisions? For that matter, were there any criteria? What motivated
parliamentarians from Canada and elsewhere to prohibit certain substances, to
control access to certain others, and to permit still others to be sold over
the counter? Knowing
where you have been helps you to understand where you are going. That is the goal of this chapter, which
retraces the evolution of Canadian drug laws from 1908 to the present day.[4][4] We have identified three legislative
periods. The first, and longest, spans the years from 1908 to 1960. That is the
period of hysteria. The second, which is much shorter, runs from 1961 to 1975
and is the period involving the search for lost reason. Lastly, the
contemporary period, which really starts at the beginning of the 1980s, is the
period of forging ahead regardless. As it would be too much to describe the
different sections in the various bills adopted over the years, we have
appended a table that explains and presents the clauses of the legislation
adopted from 1908 to 1996 on the control of narcotics. [1][1] Pires, A.P., (2002) op. cit., page 43. [2][2]
INCB (2002) pages 58-60 in particular. [3][3] Testimony by Neil Boyd, Professor of
Criminology, Simon Fraser University, before the Special Senate Committee on
Illegal Drugs, Canadian Senate, Second Session of the Thirty-Sixth Parliament,
October 16, 2000, Issue 1, page 49. [4][4] This chapter is
based largely on the excellent report prepared at the Committee’s request by
François Dubois, research assistant to Senator Pierre Claude Nolin: Le Parlement fédéral et l’évolution de la
législation canadienne sur les drogues illicites, Ottawa: Special Senate
Committee on Illegal Drugs, June 2002. This report is available on line at
www.parl.gc.ca/illegal-drugs.asp |